| Literature DB >> 26379055 |
Sophie Depiereux1, Florence Le Gac2, Bertrand De Meulder3, Michael Pierre3, Raphaël Helaers3, Yann Guiguen2, Patrick Kestemont1, Eric Depiereux3.
Abstract
Sex differentiation in fish is a highly labile process easily reversed by the use of exogenous hormonal treatment and has led to environmental concerns since low doses of estrogenic molecules can adversely impact fish reproduction. The goal of this study was to identify pathways altered by treatment with ethynylestradiol (EE2) in developing fish and to find new target genes to be tested further for their possible role in male-to-female sex transdifferentiation. To this end, we have successfully adapted a previously developed bioinformatics workflow to a meta-analysis of two datasets studying sex reversal following exposure to EE2 in juvenile rainbow trout. The meta-analysis consisted of retrieving the intersection of the top gene lists generated for both datasets, performed at different levels of stringency. The intersecting gene lists, enriched in true positive differentially expressed genes (DEGs), were subjected to over-representation analysis (ORA) which allowed identifying several statistically significant enriched pathways altered by EE2 treatment and several new candidate pathways, such as progesterone-mediated oocyte maturation and PPAR signalling. Moreover, several relevant key genes potentially implicated in the early transdifferentiation process were selected. Altogether, the results show that EE2 has a great effect on gene expression in juvenile rainbow trout. The feminization process seems to result from the altered transcription of genes implicated in normal female gonad differentiation, resulting in expression similar to that observed in normal females (i.e. the repression of key testicular markers cyp17a1, cyp11b, tbx1), as well as from other genes (including transcription factors) that respond specifically to the EE2 treatment. The results also showed that the bioinformatics workflow can be applied to different types of microarray platforms and could be generalized to (eco)toxicogenomics studies for environmental risk assessment purposes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26379055 PMCID: PMC4574709 DOI: 10.1371/journal.pone.0135799
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the meta-analysis workflow.
| Dataset 1 | Dataset 2 | |
|---|---|---|
|
|
|
|
|
| Balneation—EE2–5 concentrations : 0 (control); 0.01 ; 0.1 ; 1 and 10 μg/L | Feeding—EE2–1 concentration : 20 mg/kg food |
|
| Day 0 (D0) at 60 dpf (first feeding) up to 136 dpf | D0 at 55 dpf (first feeding) up to 111 dpf |
|
| One sampling at 136 dpf | 7 samplings at different developmental stages: D0, D0+7 days (D7), D16, D30, D63, D91, and D111 |
|
| Pools of gonads from ten fish per sample. 6 replicates per condition | Pools from 20 to 100 fish per sample. 2 replicates per condition |
|
| 8x60K oligonucleotide array (Agilent technology) | 9,023 trout cDNA platform |
|
| One-way ANOVA, with EE2 concentration as criterion | Two-way ANOVA with time-course (D0 to D111) and sex as criteria |
|
|
|
|
|
| DEGs from the four contrasts in dataset 1: CT1; CT2; CT3; CT4 | DEGs from contrasts including EE2-treated fish versus male and female control fish: MT-MC D7 to D111; MT-FC D7 to D111. |
|
| DEGs from the four contrasts in dataset 1: CT1; CT2; CT3; CT4 | DEGs from contrasts including EE2-treated fish versus male control fish: MT-MC D7 to D111. |
|
| CT1; CT2. | MT-MC D7; MT-MC D16; MT-MC D30. |
|
| DEG selected in intersection III : (i) common to pathway/Ontologies selected with intersections I and II (ii) selected by vizualization techniques (Volcanoplots and kinetic profiles) | DEG selected in intersection III : (i) common to pathway/Ontologies selected with intersections I and II (ii) selected by vizualization techniques (Volcanoplots and kinetic profiles) |
Larger gene list retrieving genes common to both datasets. This list was used for pathway analysis. We postulated that it represents mechanistic signatures of EE2 treatment on rainbow trout juveniles.
Shorter gene list retrieving genes common to both datasets. This list was used for ontology analysis. We postulated that it represents mechanistic signatures of EE2 treatment on rainbow trout juveniles.
Shortest gene list retrieving genes common to both datasets. We postulated that it focuses on genes potentially involved in early responses to EE2 treatment. This third group was selected based on union intersections, which represents DEGs common to at least one condition in dataset 1 and one condition in dataset 2 (for example DEG in CT1 and MT-MC D7).
4 [25]
Limited number of genes considered true positives after all filtering steps of the analysis workflow. We postulated that these genes are potentially implicated in male-to-female transdifferentiation processes. Gene expression profiles of this final gene list were compared with gene expression between normal (control) male and female juvenile rainbow trout.
Fig 1Flowchart of the workflow of the microarray meta-analysis methodology and associated results.
This flowchart summarizes the bioinformatics workflow used for the meta-analysis of two datasets studying sex reversal following exposure to EE2 in juvenile rainbow trout. Both datasets (dataset 1 and dataset 2, pre-treated data) were subjected to ANOVA analyses followed by Scheffe’s post hoc pairwise comparisons. Thereafter, biologically relevant sets of contrasts (coloured and in bold in the flowchart) were selected (differentially expressed genes (DEGs) between control and EE2-treated fish in dataset 1; DEGs between control and EE2-treated fish at the same developmental stage in dataset 2). The meta-analysis consisted of retrieving the intersection of the top DEGs lists generated for both datasets, performed at different levels of stringency. This allowed creating different groups of DEGs (Intersections I, II and III) for ORA analyses downstream, given that pathway or Ontologies research have different constraint concerning the group of genes to enter in the program. It is worth noting that each group of DEGs has different biological meaning described further in the text in the results section. Intersection I (low stringency) contained the intersection between all DEGs in the four contrasts in dataset 1 (CT1 to CT4) and all DEGs in the twelve contrasts including EE2-treated fish in dataset 2 (MT-MC D7 to D111, and MT-FC D7 to D111). This group contained 1,535 DEGs (1,171 DEGs having a functional annotation with Danio rerio Ensembl! identifiers-ENSARG) and was further used in the pathway overrepresentation analysis. A smaller group of DEGs (Intersection II) was obtained by retrieving the intersection between all DEGs in the four contrasts in dataset 1 (CT1 to CT4) and all DEGs in the six contrasts including EE2-treated fish versus male control fish in dataset 2 (MTMC D7 to D111). This group contained 438 DEGs (245 DEGs having a functional annotation with Swissprot identifiers) and was further used in the ontology overrepresentation analysis. The third group (Intersection III–highest stringency– 103 DEGs) was composed of the union intersection between contrasts CT1 and CT2 in dataset 1 and MT-MC D7, MT-MC D16 and MT-MC D30 in dataset 2. From this last list of DEGs, a set of most relevant DEGs was selected using volcanoplots, membership of enriched pathways and/or GOterms and kinetic profiles in both analyses. The 20 remaining genes, considered as potentially implicated in the transdifferentiation processes, were selected for further analyses.
List of significantly enriched pathways.
The list of significantly enriched pathways (P-Value/EASE score < 0.05) was obtained by using the DAVID web tool for the Intersection I group in our meta-analysis (1,535 gene IDs restricted to a set of 1,171 well annotated differentially expressed genes recognized by ENSDARG identifiers in DAVID). This group represents the genes differentially expressed following steroid modulation of immature gonads in rainbow trout by EE2, under several types of treatment. The Count column gives the number of genes of our genelist belonging to the pathway. The EASE-Score column represents the P-Value calculated by DAVID. The Benjamini column represents the Benjamini-corrected P-values (correction for multiple testing).
| Term | Count | EASE-score | Benjamini |
|---|---|---|---|
| Cell cycle | 34 | 1.1E-6 | 1.3E-4 |
| DNA replication | 15 | 2.9E-5 | 1.8E-3 |
| Oxidative phosphorylation | 29 | 6E-5 | 2.5E-3 |
| Pyrimidine metabolism | 20 | 3.7E-3 | 1.1E-1 |
| Nucleotide excision repair | 12 | 8.2E-3 | 1.8E-1 |
| Mismatch repair | 8 | 1.1E-2 | 2E-1 |
| Fatty acid elongation in mitochondria | 5 | 1.5E-2 | 2.4E-1 |
| Ribosome | 18 | 1.6E-2 | 2.2E-1 |
| PPAR signaling pathway | 12 | 3.4E-2 | 3.8E-1 |
| RNA degradation | 12 | 4.4E-2 | 4.2E-1 |
| Progesterone-mediated oocyte maturation | 16 | 4.7E-2 | 4.2E-1 |
| Valine, leucine and isoleucine degradation | 10 | 4.8E-2 | 3.9E-1 |
Fig 2Cell cycle.
In our study, the Cell Cycle is an example of a significantly enriched pathway resulting from the DAVID analysis. Red stars indicate genes belonging to the list of DEG submitted to the program. The background was made up of 16,977 Ensembl IDs (corresponding to the total number of identifiers on the Agilent 60K platform).
List of significantly enriched GO terms.
This table lists the significant GO terms (P-Value/EASE score < 0.01) retrieved by the EASE software for the Intersection II group in this analysis (245 well annotated DEGs recognized by Gene Symbol identifiers in EASE among 438 DEGs IDs). This group represents the DEGs following a steroid modulation of immature gonads in rainbow trout by EE2, under several types of treatment. The EASE-Score column represents the P-Value calculated by DAVID.
| GO ID | Term | EASE score (P-Value) |
|---|---|---|
| GO:0019953 | Sexual reproduction | 3.2E-07 |
| GO:0000003 | Reproduction | 3.2E-07 |
| GO:0007276 | Gametogenesis | 1.7E-06 |
| GO:0008283 | Cell proliferation | 5.9E-05 |
| GO:0007049 | Cell cycle | 7.2 E-05 |
| GO:0000278 | Mitotic cell cycle | 1.4E-04 |
| GO:0000074 | Regulation of cell cycle | 1.0E-03 |
| GO:0006261 | DNA dependent DNA replication | 1.0E-03 |
| GO:0005743 | Mitochondrial inner membrane | 1.0E-03 |
| GO:0009117 | Nucleotide metabolism | 1.3E-03 |
| GO:0019866 | Inner membrane | 2.0E-03 |
| GO:0005737 | Cytoplasm | 2.3E-03 |
| GO:0000279 | M phase | 3.1E-03 |
| GO:0005694 | Chromosome | 3.2E-03 |
| GO:0016491 | Oxidoreductase activity | 3.5E-03 |
| GO:0005740 | Mitochondrial membrane | 3.9E-03 |
| GO:0006220 | Pyrimidine nucleotide metabolism | 4.5E-03 |
| GO:0006260 | DNA replication | 5.1E-03 |
| GO:0006259 | DNA metabolism | 5.4E-03 |
| GO:0000084 | S phase of mitotic cell cycle | 5.8E-03 |
| GO:0048232 | Male gamete generation | 8.4E-03 |
| GO:0007283 | Spermatogenesis | 8.4E-03 |
| GO:0019201 | Nucleobase, nucleoside, nucleotide kinase activity | 9.1E-03 |
Fig 3A-E: Volcano plots.
These graphs represent the 103 DEGs belonging to the ‘Intersection 3‘ group of DEGs selected through the intersection between low doses (contrasts CT1 and CT2) in the Dataset 1 and early stages (contrasts MT-MC D7, D16 and D30) in dataset 2. For sake of clarity, red points represent DEGs. As an example, CYP11B is represented by its label. The green bars represent the log 2(+/-2) fold change and the blue bar represents a p-value threshold of 0.05. (A) Selected DEGs in contrast MTMC D7 in dataset 2. (B) Selected DEGs in contrast MTMC D16 in dataset 2. (C) Selected DEGs in contrast MTMC D30 in dataset 2. (D) Selected DEGs in contrast CT1 in dataset 1. (E) Selected DEGs in Contrast CT2 in dataset 1.
Fig 4A-B: Selected genes kinetics profiles over the several concentrations tested in dataset 1.
These graphs show the profile of the 20 DEGs retrieved by the analysis over the 4 concentrations tested in dataset 1. X-axis: EE2 concentrations (0 = control). Y-axis: fold change of the different EE2 concentrations vs CTL. A: expressions of the 10 genes also differentially expressed between female and male control fish. B: expressions of the 10 genes specific to EE2 treatment.
Fig 5A-T: Selected genes kinetics profiles over the several sampling time in dataset 2.
These graphs show the profile of the 20 DEGs retrieved by the meta-analysis in dataset 2. Moreover, a comparison between gene expression between male exposed to EE2 versus male control and the expression in a control female versus male control is made. Y-axis: fold change of gene expression between males exposed to 20mg/kg of food of ethynylestradiol (dotted lines) or control females (solid lines) at each developmental stage versus male control at the same developmental stage (contrasts MT-MC D7 to D111 and FC-MC D0 to D111, Fig 1). X-axis: sampling time. Day 0 = D0 at 55 dpf, Day 7 = D0+7 days, D16, D30, D63, D91, and D111.
Description of the 20 genes selected as physiologically relevant in the gonad transdifferentiation process.
Fold change (FC) and pvalues (Pval) are given for the five contrasts considered (CT1 and CT2 in dataset 1; MT-MC D7, D16 and D30 in dataset 2), upon which the genes were selected. Figures in bold represents significant values. The membership of genes to significantly enriched pathway and/or GO Terms is indicated.
| Gene symbol | Description | FC CT1 | Pval CT1 | FC CT2 | Pval CT2 | FC MTMC D7 | Pval MTMC D7 | FC MTMC D16 | Pval MTMC D16 | FC MTMC D30 | Pval MTMC D30 | Pathway | GO Term |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Cytochrome P450 11B |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Steroid 17-alpha-hydroxylase/17,20 lyase |
|
|
|
| -1.34 | 5.5E-01 | -1.5 | 9.1E-02 |
|
| - | Oxidoreductase activity |
|
| Cysteine and glycine-rich protein 2 |
|
|
|
| -1.39 | 5.6E-01 |
|
| -1.8 | 9.7E-02 | - | Cell proliferation |
|
| Laminin subunit beta-1 | -1.2 | 6.5E-01 |
|
|
|
|
|
|
|
| - | - |
|
| T-box transcription factor 1 | 1.1 | 9.1E-01 |
|
| -1.41 | 7.1E-01 | -2.2 | 7.1E-02 |
|
| - | Cytoplasm |
|
| Aldehyde oxidase | -1.4 | 2.8E-01 |
|
| -3.03 | 3.6E-03 |
|
|
|
| - | Oxidoreductase activity |
|
| Forkhead box protein F1 | 1.3 | 5.4E-01 |
|
| 1.27 | 6.6E-01 |
|
|
|
| - | - |
|
| Phospholipid transfer protein | 1.2 | 7.9E-01 |
|
| 1.14 | 7.7E-01 |
|
|
|
| PPAR signaling | - |
|
| Vitellogenin | 3.2 | 2.6E-01 |
|
| 2.32 | 8.3E-01 | 2.3 | 5.7E-01 |
|
| - | - |
|
| Lens fiber membrane intrinsic protein |
|
|
|
| -1.20 | 8.0E-01 | -1.7 | 7.1E-02 |
|
| - | - |
|
| Protein disulfide-isomerase | -1.5 | 5.1E-01 |
|
| -1.88 | 5.6E-01 |
| 3.8E-03 | -2.0 | 5.3E-01 | - | - |
|
| ADP-ribosylation factor-like protein 6-interacting protein 1 | 1.6 | 1.7E-02 |
|
| 1.23 | 8.4E-01 | 1.2 | 5.7E-01 |
|
| - | - |
|
| Glutathione S-transferase A | 1.4 | 2.6E-01 |
|
| 1.12 | 9.5E-01 |
| 2.2E-02 | 1.0 | 1.0E+00 | - | - |
|
| 17-beta-hydroxysteroid dehydrogenase type 6 | 1.4 | 2.6E-01 |
|
| 1.20 | 9.2E-01 | -1.4 | 5.0E-01 |
|
| - | - |
|
| Tubulin alpha chain |
|
|
|
| 1.15 | 9.5E-01 | -1.2 | 7.5E-01 |
|
| - | - |
|
| Radial spoke head 1 homolog | 1.5 | 2.1E-01 |
|
| -1.01 | 9.9E-01 | 1.2 | 1.8E-01 |
|
| - | - |
|
| Kinase D-interacting substrate of 220 kDa |
|
|
|
| 1.23 | 8.0E-01 | -1.7 | 1.0E-01 |
|
| - | - |
|
| Radial spoke head protein 9 |
|
|
|
| 1.01 | 1.0E+00 | -1.0 | 8.8E-01 |
|
| - | Cytoplasm |
|
| Tektin-1 |
|
|
|
| -1.64 | 3.5E-01 | -2.2 | 2.5E-02 |
|
| - | - |
|
| Radial spoke head protein 3 |
|
|
|
| -1.09 | 9.1E-01 | 1.5 | 8.5E-02 |
|
| - | Cytoplasm |